These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 24099103)

  • 1. The role of neutralizing antibodies in prevention of HIV-1 infection: what can we learn from the mother-to-child transmission context?
    Braibant M; Barin F
    Retrovirology; 2013 Oct; 10():103. PubMed ID: 24099103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal Binding and Neutralizing IgG Responses Targeting the C-Terminal Region of the V3 Loop Are Predictive of Reduced Peripartum HIV-1 Transmission Risk.
    Martinez DR; Vandergrift N; Douglas AO; McGuire E; Bainbridge J; Nicely NI; Montefiori DC; Tomaras GD; Fouda GG; Permar SR
    J Virol; 2017 May; 91(9):. PubMed ID: 28202762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diversity and Function of Maternal HIV-1-Specific Antibodies at the Time of Vertical Transmission.
    Doepker LE; Simonich CA; Ralph D; Shipley MM; Garrett M; Gobillot T; Vigdorovich V; Sather DN; Nduati R; Matsen FA; Overbaugh JM
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32075936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 maternal and infant variants show similar sensitivity to broadly neutralizing antibodies, but sensitivity varies by subtype.
    Mabuka J; Goo L; Omenda MM; Nduati R; Overbaugh J
    AIDS; 2013 Jun; 27(10):1535-44. PubMed ID: 23856624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal but Not Infant Anti-HIV-1 Neutralizing Antibody Response Associates with Enhanced Transmission and Infant Morbidity.
    Ghulam-Smith M; Olson A; White LF; Chasela CS; Ellington SR; Kourtis AP; Jamieson DJ; Tegha G; van der Horst CM; Sagar M
    mBio; 2017 Oct; 8(5):. PubMed ID: 29066544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal Neutralization-Resistant Virus Variants Do Not Predict Infant HIV Infection Risk.
    Milligan C; Omenda MM; Chohan V; Odem-Davis K; Richardson BA; Nduati R; Overbaugh J
    mBio; 2016 Feb; 7(1):e02221-15. PubMed ID: 26838723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coadministration of CH31 Broadly Neutralizing Antibody Does Not Affect Development of Vaccine-Induced Anti-HIV-1 Envelope Antibody Responses in Infant Rhesus Macaques.
    Dennis M; Eudailey J; Pollara J; McMillan AS; Cronin KD; Saha PT; Curtis AD; Hudgens MG; Fouda GG; Ferrari G; Alam M; Van Rompay KKA; De Paris K; Permar S; Shen X
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The breadth and potency of passively acquired human immunodeficiency virus type 1-specific neutralizing antibodies do not correlate with the risk of infant infection.
    Lynch JB; Nduati R; Blish CA; Richardson BA; Mabuka JM; Jalalian-Lechak Z; John-Stewart G; Overbaugh J
    J Virol; 2011 Jun; 85(11):5252-61. PubMed ID: 21411521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective Efficacy of Broadly Neutralizing Antibodies with Incomplete Neutralization Activity against Simian-Human Immunodeficiency Virus in Rhesus Monkeys.
    Julg B; Sok D; Schmidt SD; Abbink P; Newman RM; Broge T; Linde C; Nkolola J; Le K; Su D; Torabi J; Pack M; Pegu A; Allen TM; Mascola JR; Burton DR; Barouch DH
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralizing Antibody-Based Prevention of Cell-Associated HIV-1 Infection.
    Parsons MS; Le Grand R; Kent SJ
    Viruses; 2018 Jun; 10(6):. PubMed ID: 29912167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vertical HIV-1 Transmission in the Setting of Maternal Broad and Potent Antibody Responses.
    Tu JJ; Kumar A; Giorgi EE; Eudailey J; LaBranche CC; Martinez DR; Fouda GG; Moreau Y; Thomas A; Montefiori D; Gao F; Sagar M; Permar SR
    J Virol; 2022 Jun; 96(11):e0023122. PubMed ID: 35536018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmission of HIV-1 in the face of neutralizing antibodies.
    Blish CA; Blay WM; Haigwood NL; Overbaugh J
    Curr HIV Res; 2007 Nov; 5(6):578-87. PubMed ID: 18045114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress in immune-based interventions to prevent HIV-1 transmission to children.
    Voronin Y; Jani I; Graham BS; Cunningham CK; Mofenson LM; Musoke PM; Permar SR; Scarlatti G
    J Int AIDS Soc; 2017 Dec; 20(4):. PubMed ID: 29282882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques.
    Jones AT; Chamcha V; Kesavardhana S; Shen X; Beaumont D; Das R; Wyatt LS; LaBranche CC; Stanfield-Oakley S; Ferrari G; Montefiori DC; Moss B; Tomaras GD; Varadarajan R; Amara RR
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization.
    Rademeyer C; Korber B; Seaman MS; Giorgi EE; Thebus R; Robles A; Sheward DJ; Wagh K; Garrity J; Carey BR; Gao H; Greene KM; Tang H; Bandawe GP; Marais JC; Diphoko TE; Hraber P; Tumba N; Moore PL; Gray GE; Kublin J; McElrath MJ; Vermeulen M; Middelkoop K; Bekker LG; Hoelscher M; Maboko L; Makhema J; Robb ML; Abdool Karim S; Abdool Karim Q; Kim JH; Hahn BH; Gao F; Swanstrom R; Morris L; Montefiori DC; Williamson C
    PLoS Pathog; 2016 Jul; 12(7):e1005742. PubMed ID: 27434311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 Cross-Reactive Primary Virus Neutralizing Antibody Response Elicited by Immunization in Nonhuman Primates.
    Wang Y; O'Dell S; Turner HL; Chiang CI; Lei L; Guenaga J; Wilson R; Martinez-Murillo P; Doria-Rose N; Ward AB; Mascola JR; Wyatt RT; Karlsson Hedestam GB; Li Y
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced potency of a broadly neutralizing HIV-1 antibody in vitro improves protection against lentiviral infection in vivo.
    Rudicell RS; Kwon YD; Ko SY; Pegu A; Louder MK; Georgiev IS; Wu X; Zhu J; Boyington JC; Chen X; Shi W; Yang ZY; Doria-Rose NA; McKee K; O'Dell S; Schmidt SD; Chuang GY; Druz A; Soto C; Yang Y; Zhang B; Zhou T; Todd JP; Lloyd KE; Eudailey J; Roberts KE; Donald BR; Bailer RT; Ledgerwood J; ; Mullikin JC; Shapiro L; Koup RA; Graham BS; Nason MC; Connors M; Haynes BF; Rao SS; Roederer M; Kwong PD; Mascola JR; Nabel GJ
    J Virol; 2014 Nov; 88(21):12669-82. PubMed ID: 25142607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coverage of primary mother-to-child HIV transmission isolates by second-generation broadly neutralizing antibodies.
    Nakamura KJ; Cerini C; Sobrera ER; Heath L; Sinkala M; Kankasa C; Thea DM; Mullins JI; Kuhn L; Aldrovandi GM
    AIDS; 2013 Jan; 27(3):337-46. PubMed ID: 23296195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Antibody Response against HIV-1.
    Overbaugh J; Morris L
    Cold Spring Harb Perspect Med; 2012 Jan; 2(1):a007039. PubMed ID: 22315717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Report of the Cent Gardes HIV Vaccine Conference: The B-cell Response to HIV. Part 1: Broadly Neutralizing Antibodies Fondation Mérieux Conference Center, Veyrier du Lac, France, 5-7 November 2012.
    Girard MP; Picot V; Longuet C; Nabel GJ
    Vaccine; 2013 Jun; 31(29):2979-83. PubMed ID: 23499518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.